Kiora Pharmaceuticals Inc at OTC Markets Life Science Investor Forum Transcript
And on behalf of OTC Markets, we're very pleased you have joined us for our next slide presentation from Kiora Pharmaceuticals, a biotech company developing products for the treatment of ophthalmic diseases.
Please note, you can submit questions in the box to the left of the slides. You can also view a company's availability for one-on-one meetings through the schedule meetings tab found on the conference platform.
At this point, I'm very pleased to welcome Brian Strem, President and CEO of Kiora Pharmaceuticals, which trades on NASDAQ under the symbol KPRX.
Welcome, Brian.
Thanks, Bob. Appreciate the introduction. And inviting us to present here today. It's a pleasure to be reaching out to everyone who did join the webcast. And I look forward to walking you through the story a little bit greater as to the company, the current assets in development, and where we're looking to take the organization in the upcoming months and years
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
